Scynexis (SCYX) Cash from Operations Growth (5y) (2018 - 2026)
Scynexis (SCYX) Cash from Operations Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.42 Bn | 87.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn |
| 3 | Zoetis | 32.68 Bn | 30.74 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.63 Bn | 23.57 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.16 Bn | 21.01 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - |
| 7 | Viatris | 20.34 Bn | 18.54 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn |
| 10 | Scynexis | 23.34 Mn | -13.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -60.57% |
| Dec 31, 2025 | 25.48% |
| Sep 30, 2025 | 2.44% |
| Jun 30, 2025 | 3.28% |
| Mar 31, 2025 | 11.89% |
| Dec 31, 2024 | 5.94% |
| Sep 30, 2024 | 15.70% |
| Jun 30, 2024 | -6.96% |
| Mar 31, 2024 | 9.22% |
| Dec 31, 2023 | -5.01% |
| Sep 30, 2023 | 32.08% |
| Jun 30, 2023 | 62.75% |
| Mar 31, 2023 | -18.15% |
| Dec 31, 2022 | -34.62% |
| Sep 30, 2022 | -33.82% |
| Jun 30, 2022 | -20.28% |
| Mar 31, 2022 | -18.75% |
| Dec 31, 2021 | -41.16% |
| Sep 30, 2021 | -19.35% |
| Jun 30, 2021 | -5.40% |